149 related articles for article (PubMed ID: 37563693)
1. The value of lymph nodes ratios in the prognosis of resectable remnant gastric cancer through the retrospective propensity score matching analysis.
Yang B; Liu T; Cui H; Lu Z; Fang G; Xue X; Luo T
World J Surg Oncol; 2023 Aug; 21(1):245. PubMed ID: 37563693
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Lymph Node Staging Systems as Independent Prognosticators in Remnant Gastric Cancer Patients with an Insufficient Number of Harvested Lymph Nodes.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Takahashi K; Maezawa Y; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Cho H; Yukawa N; Yoshikawa T; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2021 May; 28(5):2866-2876. PubMed ID: 33393020
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study.
He Z; Li D; Xu Y; Wang H; Gao J; Zhang Z; Chen K
Scand J Gastroenterol; 2022 Jul; 57(7):832-841. PubMed ID: 35293268
[TBL] [Abstract][Full Text] [Related]
4. Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection.
Wang H; Qi H; Liu X; Gao Z; Hidasa I; Aikebaier A; Li K
Sci Rep; 2021 Jan; 11(1):2022. PubMed ID: 33479327
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomy.
Hu M; Zhang S; Yang X; Shen Y; Li Z; Zhao Y; Xu F; Jiang D; Wang X; Wang Y
Medicine (Baltimore); 2018 Nov; 97(44):e13079. PubMed ID: 30383693
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
Hou Y; Wang X; Chen J
World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
[TBL] [Abstract][Full Text] [Related]
7. T stage and venous invasion are crucial prognostic factors for long-term survival of patients with remnant gastric cancer: a cohort study.
Matsuo K; Lee SW; Tanaka R; Imai Y; Honda K; Taniguchi K; Tomiyama H; Uchiyama K
World J Surg Oncol; 2021 Sep; 19(1):291. PubMed ID: 34579733
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
9. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Features of Remnant Gastric Cancer After Gastrectomy.
Iwasaki K; Barroga E; Shimoda Y; Enomoto M; Yamada E; Miyoshi K; Watanabe T; Ota Y; Osaka Y; Nakagawa Y; Katsumata K; Tsuchida A
Am Surg; 2023 May; 89(5):1381-1386. PubMed ID: 34797185
[TBL] [Abstract][Full Text] [Related]
11. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of tumor deposits in gastric cancer after radical gastrectomy: a propensity score matching study.
Song X; Liu K; Liao X; Zhu Y; Peng B; Zhang W; Zhao L; Chen X; Yang K; Hu J
World J Surg Oncol; 2023 Oct; 21(1):325. PubMed ID: 37833750
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Features of Remnant Gastric Cancer (RGC): Detection of RGC after Five Years of Follow-Up Was Associated with a Poor Prognosis.
Kameda C; Kawabata R; Koga C; Matsumura T; Murakami M; Noura S; Shimizu J; Hasegawa J
Am Surg; 2019 Apr; 85(4):384-389. PubMed ID: 31043199
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor deposits in lymph node-negative gastric cancer: A propensity score matching study.
Xu R; Zhang Y; Zhao J; Chen K; Wang Z
Eur J Surg Oncol; 2023 Apr; 49(4):845-852. PubMed ID: 36543660
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.
Oh SE; An JY; Choi MG; Lee JH; Sohn TS; Bae JM
Eur J Surg Oncol; 2020 Dec; 46(12):2236-2242. PubMed ID: 32788098
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of clinicopathological features and prognosis analysis between gastric stump cancer and recurrence of gastric cancer after radical gastrectomy].
Xi H; Li J; Li S; Qiao Z; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):507-513. PubMed ID: 29774931
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and prognostic factors of remnant gastric cancer: A single-center retrospective analysis of 90 patients.
Song XH; Liu K; Sun LF; Chen XL; Zhao LY; Zhang WH; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Int J Surg; 2018 Mar; 51():97-103. PubMed ID: 29367041
[TBL] [Abstract][Full Text] [Related]
18. Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System.
Nakagawa M; Choi YY; An JY; Hong JH; Kim JW; Kim HI; Cheong JH; Hyung WJ; Choi SH; Noh SH
Ann Surg Oncol; 2016 Dec; 23(13):4322-4331. PubMed ID: 27370654
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
20. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
